Clinical profile and outcome of acute kidney injury in a tertiary care center of eastern Nepal

Author:

Singh Dipendra,Thapaliya Bishal,Bhatta Gaurab,Yadav Dipak KumarORCID,Shrestha Shailendra,Singh Jitendra,Shah Sandesh

Abstract

Background Acute kidney injury (AKI) is a global problem and it is encountered both in community and in-hospital patients. AKI has caused very significant damage to the health sector with high morbidity and mortality rates as well as a financial burden to the family. AKI contributes to a 3% incidence of end-stage renal disease (ESRD). Sepsis and hypovolemia-associated ischemia is the most common cause of AKI.  AKI has various risk factors, modes of presentation and outcomes. Also, the prevalence varies across the different populations. There is a paucity of data about the clinical profile of AKI in the eastern part of Nepal. This study aims to assess the age, comorbid conditions, the severity of AKI, mode of treatment, and outcome of patients with AKI admitted to the Nobel Medical College and Teaching Hospital, Biratnagar, Nepal. Methods This is a cross-sectional analytical study conducted at a Nobel Medical College Teaching Hospital, Biratnagar, Nepal from July 2018 to June 2019 AD. Results In this study, 192 patients diagnosed with AKI were included. Male patients accounted for 52.7%. The mean age was 48.6±18.73 years. Most of the patients (74.5%) were below <60 years of age.  The average duration of hospital stay was 8 days. The common cause of AKI was sepsis in 71.9%. Diabetes mellitus (DM) was seen in 52.6% of patients. Most of the patients (41%) were at stage III AKI at the time of admission. Hemodialysis was done in 14.6% and 85.4% were managed conservatively. Average sessions of hemodialysis were 3.61. Complete recovery was seen in 69.8% of the patients. Conclusions We observed that early diagnosis, avoidance of nephrotoxic agents, and early, aggressive, and appropriate interventions result in improved patient outcomes. However late presentations of AKI have a higher hospital mortality rate.

Publisher

F1000 Research Ltd

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference29 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3